Legend Biotech Corp ADR [NASDAQ: LEGN] plunged by -$0.93 during the normal trading session on while it closed the day at $43.09.
Legend Biotech Corp ADR stock has also loss -14.27% of its value over the past 7 days. However, LEGN stock has declined by -26.64% in the 3 months of the year. Over the past six months meanwhile, it has lost -8.55% and lost -28.39% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for LEGN stock reached $7.89 billion, with 181.91 million shares outstanding and 181.45 million shares in the current float. Compared to the average trading volume of 901.67K shares, LEGN reached a trading volume of 5573560 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Legend Biotech Corp ADR [LEGN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LEGN shares is $81.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LEGN stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Redburn Atlantic have made an estimate for Legend Biotech Corp ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 08, 2024. While these analysts kept the previous recommendation, Truist raised their target price to Buy. The new note on the price target was released on June 17, 2024, representing the official price target for Legend Biotech Corp ADR stock. Previously, the target price had yet another drop from $86 to $73, while H.C. Wainwright kept a Buy rating on LEGN stock.
The Average True Range (ATR) for Legend Biotech Corp ADR is set at 2.52, with the Price to Sales ratio for LEGN stock in the period of the last 12 months amounting to 17.31. The Price to Book ratio for the last quarter was 6.81, with the Price to Cash per share for the same quarter was set at 7.06.
LEGN stock trade performance evaluation
Legend Biotech Corp ADR [LEGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.27. With this latest performance, LEGN shares dropped by -13.66% in over the last four-week period, additionally sinking by -8.55% over the last 6 months – not to mention a drop of -36.37% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LEGN stock in for the last two-week period is set at 33.84, with the RSI for the last a single of trading hit 28.96, and the three-weeks RSI is set at 36.90 for Legend Biotech Corp ADR [LEGN]. The present Moving Average for the last 50 days of trading for this stock 51.68, while it was recorded at 46.34 for the last single week of trading, and 52.78 for the last 200 days.
Legend Biotech Corp ADR [LEGN]: An insightful look at the core fundamentals
Legend Biotech Corp ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.78 and a Current Ratio set at 4.84.
Earnings per share (EPS) analysis for Legend Biotech Corp ADR [LEGN] stock
With the latest financial reports released by the company, Legend Biotech Corp ADR posted -0.34/share EPS, while the average EPS was predicted by analysts to be reported at -0.68/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.34. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LEGN.
Legend Biotech Corp ADR [LEGN]: Institutional Ownership
The top three institutional holders of LEGN stocks are: FMR LLC with ownership of 17.62 million shares, which is approximately 9.6819%. PRICE T ROWE ASSOCIATES INC /MD/, holding 11.49 million shares of the stock with an approximate value of $$508.86 million in LEGN stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $$332.48 million in LEGN stock with ownership which is approximately 4.1246%.
